1 December 2024 v2026.20.2 limited_company_frs_102_section_1a_v1_1_3 companies_houseSoftwarefalsetruetruetrueNo description of principal activityfalsexbrli:purexbrli:sharesiso4217:GBP110882682024-12-012025-11-30110882682025-11-3011088268bus:Director12024-12-012025-11-3011088268bus:Director22024-12-012025-11-3011088268bus:RegisteredOffice2024-12-012025-11-30110882682023-12-012024-11-301108826872023-12-012024-11-30110882682024-11-3011088268core:WithinOneYear2025-11-3011088268core:WithinOneYear2024-11-3011088268core:ShareCapital2025-11-3011088268core:ShareCapital2024-11-3011088268core:RetainedEarningsAccumulatedLosses2025-11-3011088268core:RetainedEarningsAccumulatedLosses2024-11-3011088268core:ShareCapital2023-12-0111088268core:RetainedEarningsAccumulatedLosses2023-12-01110882682023-12-0111088268core:RetainedEarningsAccumulatedLosses32023-12-012024-11-3011088268core:RetainedEarningsAccumulatedLosses2023-12-012024-11-3011088268core:ShareCapital2024-12-0111088268core:RetainedEarningsAccumulatedLosses2024-12-01110882682024-12-0111088268core:RetainedEarningsAccumulatedLosses2024-12-012025-11-3011088268core:PlantMachinery2025-11-3011088268core:PlantMachinery2024-12-0111088268core:PlantMachinery2024-12-012025-11-3011088268core:PlantMachinery2024-11-3011088268core:CostValuation2024-12-0111088268core:DisposalsRepaymentsInvestments2025-11-301108826812024-12-012025-11-3011088268countries:EnglandWales2024-12-012025-11-3011088268bus:AuditExemptWithAccountantsReport2024-12-012025-11-3011088268bus:PrivateLimitedCompanyLtd2024-12-012025-11-3011088268bus:SmallEntities2024-12-012025-11-3011088268bus:FullAccounts2024-12-012025-11-30
Company registration number:
11088268
Easihealth Ltd
Unaudited Financial Statements for the year ended
30 November 2025
Easihealth Ltd
Officers and Professional Advisers
Year ended
30 November 2025
Directors
T Hussain
I Shaheen
Registered office
7 Broomcroft Close
Woking
GU22 8NR
England
Accountant
Syed Accountants Ltd
Office 204, 10 Courtenay Road
East Lane, Wembley
London
HA9 7ND
United Kingdom
Easihealth Ltd
Directors' Report
Year ended
30 November 2025
The directors present their report and the unaudited
financial statements
of the company for the year ended 30 November 2025.

Directors

The directors who served the company during the year were as follows:
T Hussain
I Shaheen

Small company provisions

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on
9 June 2026
and signed on behalf of the board by:
T Hussain
Director
Easihealth Ltd
Report to the board of directors on the preparation of the unaudited statutory financial statements of Easihealth Ltd
Year ended
30 November 2025
In order to assist you to fulfil your duties under the Companies Act 2006, I have prepared for your approval the
financial statements
of
Easihealth Ltd
for the year ended
30 November 2025
which comprise the income statement, statement of total comprehensive income, statement of financial position, statement of changes in equity and related notes from the company’s accounting records and from information and explanations you have given me.
As a practising member of the Association of Chartered Certified Accountants, I am subject to its ethical and other professional requirements which are detailed at https://www.accaglobal.com/​content/​dam/​ACCA_Global/​Members/​Doc/​rule/​2018-rulebook.pdf.
This report is made solely to the Board of Directors of
Easihealth Ltd
, as a body. My work has been undertaken solely to prepare for your approval the
financial statements
of
Easihealth Ltd
and state those matters that I have agreed to state to the Board of Directors of
Easihealth Ltd
, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at https://www.accaglobal.com/​content/​dam/​ACCA_Global/​Technical/​fact/​tf-163-jan-24.pdf. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than
Easihealth Ltd
and its Board of Directors, as a body, for my work or for this report.
It is your duty to ensure that
Easihealth Ltd
has kept adequate accounting records and to prepare statutory
financial statements
that give a true and fair view of the assets, liabilities, financial position and loss of
Easihealth Ltd
. You consider that
Easihealth Ltd
is exempt from the statutory audit requirement for the year.
I have not been instructed to carry out an audit or a review of the financial statements of Easihealth Ltd. For this reason, I have not verified the accuracy or completeness of the accounting records or information and explanations you have given to me and I do not, therefore, express any opinion on the statutory financial statements.
Syed Accountants Ltd
Office 204, 10 Courtenay Road
East Lane, Wembley
London
HA9 7ND
United Kingdom
Easihealth Ltd
Income Statement
Year ended
30 November 2025
20252024
Note££
Turnover
4,421,567
 
3,146,658
 
Cost of sales
(4,010,286
 ) (2,627,281 )
Gross profit
411,281
 
519,377
 
Distribution costs
(58,039
 )
(56,166
 )
Administrative expenses
(328,066
 )
(243,652
 )
Operating profit
25,176
 
219,559
 
Profit before tax 4
25,176
 
219,559
 
Tax on profit
(82,387
 )
(55,294
 )
(Loss)/profit for the financial year
(57,211
 )
164,265
 
Easihealth Ltd
Statement of Total Comprehensive Income
Year ended
30 November 2025
20252024
££
(Loss)/profit for the financial year
(57,211
 )
164,265
 
Reclassification from other reserves to profit and loss account -  
(247,981
 )
Total comprehensive income
(57,211
 )
(83,716
 )
Easihealth Ltd
Statement of Financial Position
30 November 2025
20252024
Note££
Fixed assets    
Tangible assets 6
904,978
 
1,209,351
 
Investments 7 -  
150,000
 
904,978
 
1,359,351
 
Current assets    
Stocks
180,000
 
140,675
 
Debtors 8
673,142
 
489,792
 
Cash at bank and in hand
215,546
 
149,851
 
1,068,688
 
780,318
 
Creditors: amounts falling due within one year 9
(327,086
 )
(239,878
 )
Net current assets
741,602
 
540,440
 
Total assets less current liabilities 1,646,580   1,899,791  
Capital and reserves    
Called up share capital
100
 
100
 
Profit and loss account
1,646,480
 
1,899,691
 
Shareholders funds
1,646,580
 
1,899,791
 
For the year ending
30 November 2025
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These
financial statements
have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
These
financial statements
were approved by the board of directors and authorised for issue on
9 June 2026
, and are signed on behalf of the board by:
T Hussain
Director
Company registration number:
11088268
Easihealth Ltd
Statement of Changes in Equity
Year ended
30 November 2025
Called up share capitalProfit and loss accountTotal
£££
At 1 December 2023
100
 
2,058,407
 
2,058,507
 
Profit for the year- 164,265 164,265 
Other comprehensive income for the year:      
Reclassification from other reserves to profit and loss account- 
(247,981
)
(247,981
)
Total comprehensive income for the year- 
(83,716
)
(83,716
)
Dividends declared and paid or payable during the year- 
(75,000
)
(75,000
)
Total investments by and distributions to owners- 
(75,000
)
(75,000
)
At 30 November 2024 and 
1 December 2024
100
 
1,899,691
 
1,899,791
 
Loss for the year- (57,211)(57,211)
Total comprehensive income for the year- 
(57,211
)
(57,211
)
Dividends declared and paid or payable during the year- 
(196,000
)
(196,000
)
Total investments by and distributions to owners- 
(196,000
)
(196,000
)
At
30 November 2025
100
 
1,646,480
 
1,646,580
 
Easihealth Ltd
Notes to the Financial Statements
Year ended
30 November 2025

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
7 Broomcroft Close
,
Woking
,
GU22 8NR
, England.

2 Statement of compliance

These
financial statements
have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable to the UK and Republic of Ireland'.

3 Accounting policies

Basis of preparation

The
financial statements
have been prepared on the historical cost basis, as modified by the revaluation of certain assets.
The
financial statements
are prepared in sterling, which is the functional currency of the company.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer, usually on despatch of the goods; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Current tax

Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Tangible assets

Tangible assets are initially measured at cost, and are subsequently measured at cost less any accumulated depreciation and accumulated impairment losses or at a revalued amount.
Any tangible assets carried at a revalued amount are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
An increase in the carrying amount of an asset as a result of a revaluation is recognised in other comprehensive income and accumulated in capital and reserves. However, the increase is recognised in profit or loss to the extent that it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves. If a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess is recognised in profit or loss.

Fixed asset investments

Investments in subsidiaries, associates and joint ventures accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses.
Investments in subsidiaries, associates and joint ventures accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income or profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted.
Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Other fixed asset investments which are listed are measured at fair value with changes in fair value being recognised in profit or loss.
All other Investments held as fixed assets are initially recorded at cost, and are subsequently stated at cost less any accumulated impairment losses.

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.

Financial instruments

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price and are subsequently measured as follows: Debt instruments are subsequently measured at amortised cost and commitments to receive a loan and to make a loan to another entity are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment.
All other financial instruments, including derivatives, are initially recognised at fair value, which is normally the transaction price and are subsequently measured at fair value, with any changes recognised in profit or loss.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.
All equity instruments regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics.
Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Defined contribution pension plan

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund.

4 Profit/loss before tax

Profit/loss before tax is stated after charging/(crediting):
20252024
££
Depreciation of tangible assets
304,373
 
3,250
 

5 Average number of employees

The average number of persons employed by the company during the year was
26
(2024:
22
).

6 Tangible assets

Plant and machinery etc.
£
Cost  
At
1 December 2024
and
30 November 2025
1,219,161
 
Depreciation  
At
1 December 2024
9,810
 
Charge
304,373
 
At
30 November 2025
314,183
 
Carrying amount  
At
30 November 2025
904,978
 
At 30 November 2024
1,209,351
 

7 Investments

Loans to group undertakings and participating interests
£
Cost  
At
1 December 2024
150,000
 
Disposals
(150,000
 )
At
30 November 2025
 -  
Impairment  
At
1 December 2024
and
30 November 2025
 -  
Carrying amount  
At
30 November 2025
 -  
At 30 November 2024
150,000
 

8 Debtors

20252024
££
Trade debtors
624,430
 
439,434
 
Other debtors
48,712
 
50,358
 
673,142
 
489,792
 

9 Creditors: amounts falling due within one year

20252024
££
Trade creditors
244,699
 
184,584
 
Taxation and social security
82,387
 
55,294
 
327,086
 
239,878